Revenue
$36,000
▼ 41.0% YoY
Net Income
-$274.4M
▲ 20.0% YoY
EPS
$-16.06
▲ 38.8% YoY
Cash
$60.2M
▼ 43.0% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Seely Lynn President and CEO | Sell | Aug 21, 2026 | 9.6K | $15.54 | $149K | Form 4 ↗ |
Hill Stephen J. Chief Operating Officer | Sell | Aug 21, 2026 | 989 | $15.54 | $15K | Form 4 ↗ |
Lee Gary K. Chief Scientific Officer | Sell | Aug 21, 2026 | 1.5K | $15.54 | $23K | Form 4 ↗ |
Bulis Veronica Sanchez VP, Corporate Controller | Sell | Aug 10, 2026 | 621 | $14.34 | $9K | Form 4 ↗ |
Lee Gary K. Chief Scientific Officer | Sell | Aug 10, 2026 | 131 | $14.34 | $2K | Form 4 ↗ |
Hill Stephen J. Chief Operating Officer | Sell | Aug 10, 2026 | 89 | $14.34 | $1K | Form 4 ↗ |
Seely Lynn President and CEO | Sell | Aug 10, 2026 | 390 | $14.34 | $6K | Form 4 ↗ |
Innovative Cellular Therapeutics Holdings Ltd Insider | Sell | Jul 27, 2026 | 44.0K | $0.00 | $0 | Form 4 ↗ |
Innovative Cellular Therapeutics Holdings Ltd Insider | Sell | Jul 27, 2026 | 38.5K | $0.00 | $0 | Form 4 ↗ |
Innovative Cellular Therapeutics Holdings Ltd Insider | Sell | Jul 17, 2026 | 10 | $13.70 | $137 | Form 4 ↗ |
Innovative Cellular Therapeutics Holdings Ltd Insider | Sell | Jul 16, 2026 | 10 | $13.73 | $137 | Form 4 ↗ |
Innovative Cellular Therapeutics Holdings Ltd Insider | Sell | Jun 29, 2026 | 76.0K | $0.00 | $0 | Form 4 ↗ |